Wednesday, October 4, 2023
Market-Reporter
  • Home
  • Markets
    • U.S. Markets
    • Canada
    • Europe & Middle East
    • Emerging Markets
    • Asia
    • Latin America
  • Investing
    • Stocks
    • IPOs
    • Mutual Funds
    • ETFs
    • Bonds
    • Commodities
    • Currencies
    • Cryptocurrencies
  • Economy & Politics
    • Personal Finance
    • Spending & Saving
    • Retirement
    • Real Estate
No Result
View All Result
  • Home
  • Markets
    • U.S. Markets
    • Canada
    • Europe & Middle East
    • Emerging Markets
    • Asia
    • Latin America
  • Investing
    • Stocks
    • IPOs
    • Mutual Funds
    • ETFs
    • Bonds
    • Commodities
    • Currencies
    • Cryptocurrencies
  • Economy & Politics
    • Personal Finance
    • Spending & Saving
    • Retirement
    • Real Estate
No Result
View All Result
Market-Reporter
No Result
View All Result
Home Stocks

These Stocks Are Better Priced Compared To Abbott

MtR by MtR
June 21, 2021
in Stocks
0
These Stocks Are Better Priced Compared To Abbott


ABBOTT PARK, IL – FEBRUARY 10: Abbott Laboratories signage is visible on the campus of its … [+] headquarters February 10, 2004 in Abbott Park, Illinois. Abbott Laboratories has announced that it has received approval from the U.S. Food and Drug Administration (FDA) for 11 diagnostic assays for hepatitis, prostate specific antigen (PSA) and alpha-fetoprotein (AFP). Also, investigators in Illinois and New York, including Illinois Attorney General Lisa Madigan, are investigating the Abbott Park, Illinois-based health care company’s pricing of their AIDS medicine Norvir after its cost increased nearly 400 percent. Abbott Laboratories, a global, diversified health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals, nutritionals, and medical products, including devices and diagnostics, employs more than 70,000 people, marketing its products in more than 130 countries. (Photo by Tim Boyle/Getty Images)


Getty Images

We believe that there are other stocks in the healthcare sector that are currently better valued than Aboott Laboratories (NYSE: ABT). Abbott’s current price-to-operating income ratio (P/EBIT) of 30x is much higher than levels of under 12x for PerkinElmer, and 4x for Quidel. Both of these stocks have a lower valuation (P/EBIT) compared to Abbott, while both of them have seen higher revenue and operating income growth. This disconnect between valuation and performance could mean that you are better off buying PKI and QDEL vs. ABT. More specifically, we arrive at our conclusion by looking at historical trends in revenues, operating income, and P/EBIT for these companies. Our dashboard Better Bet Than Abbott Stock: Pay Less To Get More From Sector Peers PKI, QDEL has more details – parts of which are summarized below.

ADVERTISEMENT

1. Revenue Growth

Abbott’s revenue grew at an average rate of 8.2% over the last three years, as compared to revenue growth of 19.0% for PerkinElmer, and a large 100% for Quidel. Even if we look at the revenue growth over the last twelve month period, Abbott’s top-line growth of 16% is much lower than 54% for PerkinElmer and a whopping 211% for Quidel.

Related articles

World’s biggest bond markets hit by relentless selling

World’s biggest bond markets hit by relentless selling

October 4, 2023
India’s palm imports fall more than a quarter in Sept as stocks surge -dealers

India’s palm imports fall more than a quarter in Sept as stocks surge -dealers

October 4, 2023

Abbott’s revenue growth over the recent past has been driven by higher diagnostics sales, primarily from its Covid-19 tests, which more than offset the decline seen in other segments, primarily medical devices, due to postponement of elective surgeries due to the impact of the pandemic, in the first half of 2020. PerkinElmer sales were also higher due to massive demand for Covid-19 tests, offsetting the decline in other businesses. In fact, the same is the case for Quidel, which saw its sales surge due to higher demand for testing.

2. Operating Income Growth

The three-year average operating income growth for Abbott stands at 57%, lower than 68% for PerkinLemer, and a large 409% for Quidel. Better revenue growth as well as margin expansion for the latter two led to higher operating income for these companies. Looking at the last twelve month period, Abbott’s 49% growth in operating income is much lower than the 297% for PerkinElmer and over 1000% for Quidel. The operating margins for Quidel surged to 64.4% in 2020, compared to just 9.8% in 2017. Much of this growth came over the last twelve-month period, when demand for Covid-19 testing was very high across the globe.

EPS


Trefis

The Net of It All

Although Abbott’s revenue base is much larger than PerkinElmer and Quidel, both of these companies have seen higher growth in revenues and operating income than Abbott in the last twelve months as well as the last three years. Yet, they appear to be valued significantly lower than Abbott. Why is that? To some extent, the gap in valuation does make sense, given that there are valid concerns of future sales growth, especially for Quidel. Abbott is far more diversified compared to PerkinElmer and Quidel, and when Covid-19 testing declines, Abbott’s other business segments, primarily medical devices, will drive the revenue growth. For PerkinElmer, there will likely be a rebound in the demand for life science research, food, environmental and industrial testing.

While there is no denying that Quidel will see a decline in sales, as the Covid-19 crisis winds down, some of the demand for testing will likely remain over the next few years, boding well for all three companies, but more meaningful for Quidel, given its high reliance on tests. Overall, we think that this gap in valuation will eventually narrow over time to favor the group of comparatively less expensive names. As such, we believe that PKI and QDEL are currently better buying opportunities compared to ABT stock.

While QDEL and PKI stocks may outperform ABT in the near term, 2020 has created many pricing discontinuities which can offer attractive trading opportunities. For example, you’ll be surprised how counter-intuitive the stock valuation is for Johnson & Johnson vs Quest Diagnostics

DGX
.

ADVERTISEMENT

See all Trefis Featured Analyses and Download Trefis Data here



Source link

Related Posts

World’s biggest bond markets hit by relentless selling

World’s biggest bond markets hit by relentless selling

by MtR
October 4, 2023
0

Euro, Hong Kong dollar, U.S. dollar, Japanese yen, pound and Chinese 100 yuan banknotes are seen in this picture illustration,...

India’s palm imports fall more than a quarter in Sept as stocks surge -dealers

India’s palm imports fall more than a quarter in Sept as stocks surge -dealers

by MtR
October 4, 2023
0

MUMBAI, Oct 4 (Reuters) - India's imports of edible oil fell 19% in September from August's record as refiners curtailed...

ASX falls led by tech stocks, US bond yield surge jolts Wall Street, VIX fear gauge jumps

ASX falls led by tech stocks, US bond yield surge jolts Wall Street, VIX fear gauge jumps

by MtR
October 4, 2023
0

The Australian sharemarket is extending to fresh six-month lows this afternoon, tracking losses on Wall Street after stronger-than-expected jobs data...

Tech stocks still sliding after closing out their worst month of 2023

Tech stocks still sliding after closing out their worst month of 2023

by MtR
October 3, 2023
0

The Nasdaq fell 1.9% on Tuesday, pacing a broader market decline that was sparked by concerns of rising interest rates.Airbnb...

Stocks Slump as Bond Yields Rise on Jump in Job Openings

Stocks Slump as Bond Yields Rise on Jump in Job Openings

by MtR
October 3, 2023
0

Dow Turns Negative For the Year 37 minutes ago The Dow Jones Industrial Average fell more than 350 points, or...

Load More
  • Trending
  • Comments
  • Latest
Bank of England tells ministers to intervene on digital currency ‘programming’

Bank of England tells ministers to intervene on digital currency ‘programming’

June 21, 2021
Tips for checking smoke alarms during daylight saving time

Tips for checking smoke alarms during daylight saving time

March 12, 2022
GLOBAL MARKETS-U.S. stocks follow Europe up; Treasury yields rise, dollar firm

GLOBAL MARKETS-U.S. stocks follow Europe up; Treasury yields rise, dollar firm

July 9, 2021
What will Durham County education bonds pay for? A full list

What will Durham County education bonds pay for? A full list

July 8, 2022
African currencies week ahead: Zambia's kwacha seen on back foot, Kenyan shilling up – Business Recorder

African currencies week ahead: Zambia's kwacha seen on back foot, Kenyan shilling up – Business Recorder

0
Maxum Foods releases Global Dairy Commodity Update for June

Maxum Foods releases Global Dairy Commodity Update for June

0
Letter: Perpetual bonds can help states fight hunger

Letter: Perpetual bonds can help states fight hunger

0
United Kingdom ETFs Are Riding the Re-Opening Momentum

United Kingdom ETFs Are Riding the Re-Opening Momentum

0
Interest in office conversion grows while Edmonton market is stable

Interest in office conversion grows while Edmonton market is stable

October 4, 2023
World’s biggest bond markets hit by relentless selling

World’s biggest bond markets hit by relentless selling

October 4, 2023
Taylor Swift Economy Is Bad News for Bonds

Taylor Swift Economy Is Bad News for Bonds

October 4, 2023
How birds hover in flight is inspiring the next generation of energy-saving drones

How birds hover in flight is inspiring the next generation of energy-saving drones

October 4, 2023

Recent News

Interest in office conversion grows while Edmonton market is stable

Interest in office conversion grows while Edmonton market is stable

October 4, 2023
World’s biggest bond markets hit by relentless selling

World’s biggest bond markets hit by relentless selling

October 4, 2023
Taylor Swift Economy Is Bad News for Bonds

Taylor Swift Economy Is Bad News for Bonds

October 4, 2023

Categories

  • Asia
  • Bonds
  • Canada
  • Commodities
  • Cryptocurrencies
  • Currencies
  • Emerging Markets
  • ETFs
  • Europe & Middle East
  • IPOs
  • Latin America
  • Mutual Funds
  • Personal Finance
  • Real Estate
  • Retirement
  • Spending & Saving
  • Stocks
  • U.S. Markets
  • Privacy & Policy
  • About Us
  • Contact Us
  • Advertise with us

© 2021 Copyright Market-Reporter

No Result
View All Result
  • Home
  • Markets
    • U.S. Markets
    • Canada
    • Europe & Middle East
    • Emerging Markets
    • Asia
    • Latin America
  • Investing
    • Stocks
    • IPOs
    • Mutual Funds
    • ETFs
    • Bonds
    • Commodities
    • Currencies
    • Cryptocurrencies
  • Economy & Politics
    • Personal Finance
    • Spending & Saving
    • Retirement
    • Real Estate

© 2021 Copyright Market-Reporter